-
- 1800 2010
- EN
-1366x0.jpg)
News
Array
(
[0] => stdClass Object
(
[id] => 1210
[id_crawler] =>
[category_product] => NULL
[thumbnail] => vtv05065.jpg
[album] =>
[url_video] =>
[is_status] => 1
[is_featured] => 0
[is_form] => 0
[displayed_time] => 2024-05-20
[program] => 0
[number] => 1
[viewed] => 0
[type] =>
[type_career] =>
[level] =>
[address] =>
[address_career] =>
[expiration_time] => 0000-00-00
[created_time] => 2024-05-21 10:04:16
[updated_time] => 2024-09-04 08:50:01
[files] =>
[salary] =>
[time] =>
[created_by] => 63
[is_table_content] => 1
[language_code] => en
[slug] => GENTIS-&-Hanoi-Hospital-of-Androilogy-and-infertility-lighting-up-the-dreams-of-infertile-families
[title] => GENTIS & Hanoi Hospital of Andrology and Infertility: Lighting Up the Dreams of Infertile Families
[description] => On the morning of May 19, 2024, the Hanoi Andrology and Infertility Hospital successfully held the Closing Ceremony for the 2024 Golden Week Program and the 15th Anniversary (2009 – 2024) with the theme: "Lighting Up the Dreams of Infertile Families.”
[content] => GENTIS is honored to be the main sponsor of the program, accompanying the hospital in spreading humanitarian values and sharing love with the infertile community, along with meaningful reunions of hundreds of couples who have successfully undergone assisted reproductive treatments at the hospital.
The program was organized with thousands of guests attending, including Prof. Nguyen Dinh Tao, PhD.MD. – President of Hanoi Society of Assisted Reproduction; Assoc.Prof.Nguyen Quang, PhD. – President of Vietnam Society for Sexual Medicine;... and the leadership of Hanoi Andrology and Infertility Hospital: Mr. Le Trung Hieu – Chairman of the Board of Directors, Le Thi Thu Hien, MSc.MD. – Medical Director, Specialist level 1 Pham Van Huong, MD. – Deputy Medical Director and Head of the Assisted Reproduction Department;... among many other infertile couples from across the country.
At the opening of the ceremony, Mr. Nguyen Van Cuong – Executive Director of the hospital, said, "With the core values of 'Dedication – Trust – Quality' embedded in all our activities, the hospital has successfully performed tens of thousands of IVF cycles with a high success rate. Alongside professional development, the hospital continuously strives to improve services, invest in modern equipment, and optimize treatment effectiveness to provide international-standard service experiences at an affordable cost for the majority of the population."
The year 2024 marks the 10th year of the “Golden Week” program. The positive response and support from the community have motivated the hospital to continue implementing it over the years. Since 2015, thousands of couples have received support from the “Golden Week” program of Hanoi Andrology and Infertility Hospital, with over 50 disadvantaged families receiving 100% IVF financial aid, resulting in the birth of 59 babies; more than 400 cases of free services through file review with a total support value of billions of VND; nearly 600 lucky support packages worth from 5 to 100 million VND.
Le Thi Thu Hien, MSc.MD. - Medical Director of the hospital said: “… We are truly happy because the Golden Week not only brings humanitarian values to the community but also serves as a bridge for everyone to understand and share with infertile families longing for children, breaking down psychological barriers, social prejudices, and spreading love in the community.”
This year, the program took place over two weeks, from May 6 to May 19, 2024. To celebrate the hospital’s 15th anniversary, the "Golden Week 2024" increased the number of support packages covering 100% of IVF costs from 10 to 15 cases, through a file approval process. Additionally, the program offered 105 other fully funded cases, creating a humanitarian journey, a unique mark of AF HANOI, helping thousands of infertile families across the country.
The desire to have children always lingers and creates an invisible pressure on infertile couples. Many families turn to methods such as in vitro fertilization or artificial insemination, but fail multiple times due to carrying genetic disorders like hemophilia, spinal muscular atrophy, etc. Understanding these hardships and desiring to assist families on their journey to parenthood, GENTIS has joined this major event as the main sponsor, providing various forms of support.
Sharing about the program, Mr. Do Manh Ha – CEO of GENTIS, expressed his great honor in partnering with it. This is an incredibly meaningful program aimed at helping infertile couples on their journey to have children. He hopes that GENTIS will always be a long-term companion with the hospital to contribute to supporting difficult and infertile families and turning the dream of parenthood into reality.
In the future, GENTIS promises to continuously strive, update, and develop more research and tests to best serve infertile couples, working together to achieve the sacred dream for all families across the country.
[content_more] =>
[meta_title] => GENTIS & Hanoi Hospital of Andrology and Infertility: Lighting Up the Dreams of Infertile Families
[meta_description] => the Hanoi Andrology and Infertility Hospital successfully held the Closing Ceremony for the 2024 Golden Week Program and the 15th Anniversary (2009 – 2024) with the theme: "Lighting Up the Dreams of Infertile Families.”
[meta_keyword] => Gentis,Infertility,Families
[thumbnail_alt] =>
[post_id] => 1210
[category_id] => 4
)
[1] => stdClass Object
(
[id] => 1209
[id_crawler] =>
[category_product] => NULL
[thumbnail] => 444481185_841234898024129_3189960691457422437_n.jpg
[album] =>
[url_video] =>
[is_status] => 1
[is_featured] => 0
[is_form] => 0
[displayed_time] => 2024-05-20
[program] => 0
[number] => 1
[viewed] => 0
[type] =>
[type_career] =>
[level] =>
[address] =>
[address_career] =>
[expiration_time] => 0000-00-00
[created_time] => 2024-05-21 09:56:32
[updated_time] => 2024-09-04 11:45:39
[files] =>
[salary] =>
[time] =>
[created_by] => 63
[is_table_content] => 1
[language_code] => en
[slug] => Gentis-participated-in-the-lauch-ceremony-of-the-dft-1:1-model-optimizing-ivf-success-rates-at-phuong-dong-general-hospital
[title] => GENTIS participated in the launch ceremony of the "DFT 1:1 Model - Optimizing IVF Success Rates" at Phuong Dong General Hospital
[description] => The launch of the "DFT 1:1 Model - Optimizing IVF Success Rates" on May 18, 2024, is considered the biggest assisted productive event of the year hosted by High-Tech Center of Infertility and Andrology of Phuong Dong General Hospital.
[content] => 
With a growing desire to help more families realize their dream of parenthood, the launch ceremony of the DFT 1:1 Model - Optimizing IVF Success Rates was held. This event provided an opportunity for aspiring parents to gain knowledge, receive direct consultation from doctors, and feel more prepared to welcome their baby successfully.
The launch ceremony was graced by the presence of Assoc. Prof. Nguyen Trung Chinh, MD., Director of Phuong Dong General Hospital, and Distinguished Physician, Specialist level II doctor Han Van Ba, Deputy Director of Phuong Dong General Hospital, along with numerous doctors, guests, and over 100 couples struggling with infertility.
As the main sponsor, GENTIS had the honor of introducing to doctors, experts, and IVF patients advanced testing packages that significantly contribute to assisted reproductive progress.
Within the framework of the launch ceremony, a panel discussion titled "Optimizing IVF Success Rates" brought together experts in assisted reproduction to share valuable insights and knowledge with couples seeking fertility treatment.
Notably, Nguyen Quang Vinh, MSc., Director of GENTIS Testing Center, provided detailed information on the advantages of embryo screening tests, including the detection of single-gene genetic disorders, chromosomal structural rearrangements, chromosomal number abnormalities, etc.
M.S. Vinh shared an overview of preimplantation genetic testing (PGT) and its significant role in increasing IVF success rates.
He particularly emphasized PGT-Max 1, an upgraded version of PGTest with high resolution, capable of detecting common microdeletions larger than 2Mb associated with DiGeorge Syndrome and 1p36 deletion.
As a leading pioneer in genetic analysis in Vietnam, GENTIS is committed to bringing the world's most advanced testing services and packages to our clients and partners, with the goal of enhancing the physical and intellectual well-being of Vietnamese people. Congratulations once again on the successful launch event.
[content_more] =>
[meta_title] => GENTIS participated in the launch ceremony at Phuong Dong General Hospital
[meta_description] => The launch of the "DFT 1:1 Model - Optimizing IVF Success Rates" on May 18, 2024, is considered the biggest assisted productive event of the year hosted by High-Tech Center of Infertility and Andrology of Phuong Dong General Hospital.
[meta_keyword] => Gentis,IVF,Assisted Reproductive
[thumbnail_alt] =>
[post_id] => 1209
[category_id] => 4
)
[2] => stdClass Object
(
[id] => 1208
[id_crawler] =>
[category_product] => NULL
[thumbnail] => 0584a6f22a2a8b74d23b.jpg
[album] => 0584a6f22a2a8b74d23b.jpg
[url_video] =>
[is_status] => 1
[is_featured] => 0
[is_form] => 0
[displayed_time] => 2024-05-17
[program] => 0
[number] => 1
[viewed] => 0
[type] =>
[type_career] =>
[level] =>
[address] =>
[address_career] =>
[expiration_time] => 0000-00-00
[created_time] => 2024-05-17 09:19:51
[updated_time] => 2024-09-05 09:02:27
[files] =>
[salary] =>
[time] =>
[created_by] => 1
[is_table_content] => 0
[language_code] => en
[slug] => Gentis-service-introduction-workshop-at-hong-ngoc-phuc-truong-minh-ivf-center
[title] => GENTIS Service Introduction Workshop at Hong Ngoc Phuc Truong Minh IVF Center
[description] => On May 14th, 2024, GENTIS, in collaboration with Hong Ngoc Phuc Truong Minh Hospital's IVF Center, successfully conducted a workshop introducing the "Expanded Thalassemia Testing Package" to the center's medical staff.
[content] => With the goal of collaborating and conducting in-depth research on various testing services to support assisted reproduction, GENTIS organized a workshop introducing the "Expanded Thalassemia Testing Package" at Hong Ngoc Phuc Truong Minh Hospital's IVF Center. The workshop was attended by MSc. Hoang Thi Thuan, Head of the IVF Lab at Hong Ngoc Hospital, and over 15 medical professionals from the hospital.
The workshop was attended by the medical staff of Hong Ngọc Hospital.
Representing GENTIS, Nguyen Thi Huyen, MD.MSc. - a senior researcher and genetic consultant at GENTIS Genetic Counseling Center, participated in the workshop.
At the workshop, Nguyen Thi Huyen, MD.MSc. presented a detailed report on the expanded thalassemia testing package developed by GENTIS.
Ms. Nguyen Thi Huyen began the workshop by providing a detailed explanation of the pathogenesis of hemoglobinopathies and common thalassemia mutations in the Vietnamese population.
Dr. Nguyen Thi Huyen provided a detailed presentation on Thalassemia.
Thalassemia is the most common single-gene genetic disorder in the world. According to a 2008 report by the Thalassemia International Federation and WHO, an estimated 7% of the global population carries the thalassemia gene, and over 330,000 children are born with severe forms of the disease each year.
In Vietnam, the prevalence of the thalassemia gene is estimated to be as high as 12%, with over 12 million carriers. Thalassemia affects people from all provinces and ethnic groups across the country. Currently, there are over 20,000 people living with thalassemia and requiring lifelong treatment, and approximately 8,000 new cases are diagnosed each year, including around 2,000 severe cases and 800 fetal deaths due to fetal hydrops. (According to statistics from the Vietnam Thalassemia Association)
In order to help gene carriers be proactive in controlling and preventing Thalassemia, especially Thalassemia major as well as building a healthy community, GENTIS launches an expanded Thalassemia testing package to help detect mutations related to alpha thalassemia and beta thalassemia.
Mutations detected:
- The most common five mutations causing alpha thalassemia (-αSEA, -α3.7, -α4.2, -CS, QS)
- Over 800 mutations in the coding region of the HBB gene, including 16 common mutations (CD41/42, CD43, IVS-II-654, -28, -29, CD71/72, CD26, CD17, CD14/15, CD27/28, Cap, Int, IVS-I-1(G-T), IVS-I-1(G-A), IVS-I-5, CD31), have been reported in databases related to beta thalassemia and hemoglobinopathies. Other mutations include point mutations, deletions, and short insertions (less than 4 nucleotides) in the coding region and nearby introns (-10/+10 nucleotides from the exon) of the HBB gene.
The information about the testing package generated significant interest among the attending physicians.
The doctors showed great interest in the content of the testing package.
In response to MSc. Hoang Thi Thuan's question about the percentage of detected mutations compared to the total number of reported mutations, Ms. Nguyen Thi Huyen stated that:
“The mutations detected by GENTIS's expanded thalassemia testing package account for 97-98% of all thalassemia carriers. Additionally, GENTIS is currently researching and refining the process to develop a test that can detect even more alpha thalassemia mutations.”
The medical team's inquiries received comprehensive and specific advice.
Moreover, Dr. Huyen provided detailed and clear answers to all the questions raised by the medical team. GENTIS's expanded thalassemia testing package is an advanced test that utilizes Illumina's next-generation sequencing (NGS) technology to enhance the detection of rare mutations that are not included in traditional testing packages. The doctors unanimously agreed that this testing package is a valuable tool for both clinicians and patients in screening for this dangerous genetic disease.
[content_more] => [meta_title] => GENTIS Service Introduction Workshop at Hong Ngoc Phuc Truong Minh IVF Center [meta_description] => On May 14th, 2024, GENTIS, in collaboration with Hong Ngoc Phuc Truong Minh Hospital's IVF Center, successfully conducted a workshop introducing the "Expanded Thalassemia Testing Package" to the center's medical staff. [meta_keyword] => Thalassemia,Tests,Gentis [thumbnail_alt] => [post_id] => 1208 [category_id] => 4 ) [3] => stdClass Object ( [id] => 1207 [id_crawler] => [category_product] => NULL [thumbnail] => e1eff3ec838622d87b97.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2024-04-28 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2024-05-13 10:24:46 [updated_time] => 2024-09-05 08:54:48 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => Gentis-launches-expanded-thalassemia-test-package [title] => GENTIS Launches Expanded Thalassemia Test Package [description] => As a pioneer in the field of genetic analysis, especially the application of genetic tests in hematology, GENTIS has always strived to improve and launch an expanded thalassemia test package to effectively support doctors in diagnosis, treatment, and genetic counseling for patients with this disease. [content] =>
Thalassemia (congenital hemolysis) is the world's most common monogenic disorder. It is estimated that in the world, about 7% of the population currently carries the disease gene, over 330,000 children born annually suffer from the disease. In Vietnam, according to a report by the National Institute of Hematology and Blood Transfusion, all 63 provinces/cities and 54 ethnic groups have people carrying the disease gene. The numbers on the situation of congenital hemolytic disease in Vietnam are really alarming. It is estimated that about 14 million people carry the disease gene across the country (accounting for about 13%).
You should take an expanded thalassemia test for health screening today
According to statistics from the Vietnam Congenital Hemolysis Association, there are more than 20,000 patients who need treatment, of which 44% are children (<15 years old). Currently, more than 20,000 people with thalassemia need lifelong treatment and about 8,000 more children are born with thalassemia annually, of which about 2,000 are severely ill and about 800 cannot be born due to hydrops fetalis.
In addition, thalassemia is also a genetic disease with the highest incidence, a severe prognosis and requires large treatment costs. In fact, it also shows that the cost to prevent thalassemia is much smaller than the cost of treatment with outstanding efficiency.
Therefore, screening for thalassemia is necessary for everyone, especially those with a family history of the disease, which should be done right from the premarital stage. In case the couple unfortunately carries the disease gene, the doctor should advise on healthy childbirth measures to move towards ending the situation of the child being born with the disease and gradually reducing the inheritance rate of the disease gene in the community.
In order to help disease gene carriers be proactive in controlling and preventing thalassemia, especially severe thalassemia as well as building a healthy community, GENTIS has launched an expanded thalassemia test package to help detect gene mutations related to alpha thalassemia and beta thalassemia.
Screening Scope:
- Detection of the 5 most common mutations that cause alpha thalassemia: -αSEA; -α3.7; - α4.2; -CS; QS.
- Detection of more than 800 mutations located on the coding region of the HBB gene has been reported on databases related to beta thalassemia and hemoglobin disease, including 16 common mutations including CD41/42, CD43, IVS-II-654, -28, -29, CD71/72, CD26, CD17, CD14/15, CD27/28, Cap, Int, IVS-I-1(G-T), IVS-I-1(G-A), IVS-I-5, CD31. Other mutations include spot mutations, deletions, and short segment insertions (less than 4 nucleotides) in the coding region and neighboring introns (-10/+10 nucleotides from exons) of the HBB gene.
Note: A negative result does not exclude samples carrying duplication/deletion mutations or intels greater than 4 nucleotides.
At GENTIS, the expanded thalassemia test uses Illumina's NGS next-generation gene sequencing technology to enhance the specificity, sensitivity, and accuracy of the test. This is a technique that is considered the gold standard because it will help determine exactly whether you carry the alpha thalassemia or beta thalassemia gene. From there, it supports doctors in diagnosing and treating diseases effectively and providing reasonable reproductive advice.
In addition to the expanded thalassemia test package, GENTIS is currently providing 3 thalassemia test packages to help reduce the burden on many families, as well as society and have suitable options for the next generation to be healthy:
- β-Thalassemia Test Package: Find 16 β-Thalassemia mutations with high sensitivity and specificity using Sanger sequencing technology.
- Thalassemia 21 Mutation Test Package: Using a commercial kit with CE-IVD certification with high accuracy, 21 α and globin β mutations were detected in Vietnamese population.
- PGT-M Thalassemia Test: Pre-implantation test for Thalassemia.
In order to serve customers with advanced tests, GENTIS always invests in complete, modern facilities, ready for research as well as product improvement. Not only that, GENTIS is also proud to own a team of highly qualified, skilled staffs who are passionate and knowledgeable about technological and technical advances and constantly updating new knowledge of the industry in the world. In particular, GENTIS always has a Scientific Council with experts who are experienced researchers to "increasingly improve the physical and intellectual quality of Vietnamese people".
[content_more] => [meta_title] => GENTIS Launches Expanded Thalassemia Test Package [meta_description] => GENTIS has always strived to improve and launch an expanded thalassemia test package to effectively support doctors in diagnosis, treatment, and genetic counseling for patients with this disease. [meta_keyword] => Gentis,Thalassemia [thumbnail_alt] => [post_id] => 1207 [category_id] => 4 ) [4] => stdClass Object ( [id] => 1206 [id_crawler] => [category_product] => NULL [thumbnail] => thiết_kế_chưa_có_tên.png [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2024-04-29 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2024-05-11 15:45:25 [updated_time] => 2024-05-27 09:47:25 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => gentis-thong-bao-moi-hop-dai-hoi-dong-co-dong-thuong-nien-nam-2024 [title] => Meeting Invitation annual General Meeting of shareholders 2024 [description] => GENTIS BOD invite Shareholders to take part in the 2024 Annual General Meeting of Shareholders as follows: [content] =>
With the participation of over 2,500 delegates, including Professors, Associate Professors, Doctors, leading experts in obstetrics and gynecology within the country and abroad, the 24th Vietnam - France - Asia - Pacific Obstetrics and Gynecology Conference is one of the most valuable scientific conferences with high-quality scientific sessions and specialized reports.
Notably, the reports were divided into multiple sessions with diverse topics, catering for the interests of doctors and experts. This provided issues and solutions to help address treatments in the medical field in general and reproductive health in particular.
As a sponsor, GENTIS showcased a booth to introduce delegates to advanced prenatal screening services such as NIPT-GenEva, PGT-M detecting over 100 single genes, and more. Through the symposium, GENTIS brought its testing services closer to experts and doctors nationwide to best support them in the fields of assisted reproduction, obstetrics, and pediatrics.
Remarkably, GENTIS continues to invest in high-tech equipment combined with a team of top experts, delivering valuable genetic tests to customers and partners. In addition, GENTIS has professional genetic counselors to provide the best advice and information on testing.
During the symposium, the GENTIS booth welcomed hundreds of doctors and experts who visited to learn about genetic tests. GENTIS also expressed gratitude by giving small gifts to delegates who participated in the minigame.
With a deep commitment to improving the health and well-being of Vietnamese people, GENTIS will continue to research and develop its genetic testing services, contributing to the advancement of genetic testing and the overall growth of the medical field.
Let’s look back at the impressive images of GENTIS at the 24th Vietnam - France - Asia - Pacific Obstetrics and Gynecology Conference!
GENTIS is proud to have been accompanying the symposium over the years. In 2024, GENTIS is honored to be one of the main sponsors, partnering with Tu Du Hospital and contributing to the success of the symposium.
As a sponsor, GENTIS will introduce testing products related to assisted reproduction, obstetrics, and pediatrics, notably the PGT-M test, NIPT GenEva, and newborn screening. Additionally, visitors to the GENTIS booth will receive hundreds of valuable gifts.
The event will take place from May 9-10, 2024, at Riverside Palace Conference Center, 360D Ben Van Đon, Ward 1, District 4, Ho Chi Minh City. Don’t miss the opportunity to attend the 24th Vietnam - France - Asia - Pacific Obstetrics and Gynecology Conference on May 9-10, 2024!
GENTIS looks forward to welcoming and collaborating with esteemed doctors and experts at the conference
[content_more] => [meta_title] => GENTIS - Main Sponsor of the 24th Vietnam - France - Asia - Pacific Obstetrics and Gynecology Confer [meta_description] => The Vietnam - France - Asia - Pacific Obstetrics and Gynecology Conference, organized by Tu Du Hospital, is a significant event to obstetrics and gynecology experts [meta_keyword] => GENTIS,Obstetrics,Sponsor,Conference [thumbnail_alt] => [post_id] => 1204 [category_id] => 4 ) [7] => stdClass Object ( [id] => 1201 [id_crawler] => [category_product] => NULL [thumbnail] => cea85afa150abb54e21b.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2024-04-26 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2024-04-26 13:18:37 [updated_time] => 2024-09-04 14:22:05 [files] => [salary] => [time] => [created_by] => 1 [is_table_content] => 0 [language_code] => en [slug] => Talk-show-genetic-counseling-for-pgt-m-screening-for-embryonic-monogenic-diseases-international-recommendations-and-practices-in-vietnam [title] => TALK SHOW: "GENETIC COUNSELING FOR PGT-M SCREENING FOR EMBRYONIC MONOGENIC DISEASES: INTERNATIONAL RECOMMENDATIONS AND PRACTICES IN VIETNAM" [description] => On April 24, GENTIS Genetic Counseling Center broadcasted the 2nd Genetic Counseling - Expert Consultation Talkshow with the topic: "Genetic counseling for PGT-M testing for screening for embryonic monogenic diseases: International recommendations and practices in Vietnam" on the fanpage of GENTIS. The conversation took place successfully and attracted a lot of attention from doctors working in the field of assisted reproduction as well as couples who are in need of IVF. [content] =>At the talk show, Assoc.Prof.Tran Van Khoa, PhD.,MD., (Head of the Department of Biology - Genetics, Military Medical Academy), Pham Dinh Minh, PhD., (R&D Director of GENTIS - Director of GENTIS Genetic Counseling Center), Nguyen Thi Huyen, MSc.,MD. (Genetic Consultant at GENTIS Genetic Counseling Center - GENTIS R&D Specialist) shared their knowledge about PGT-M, international recommendations and the practical situation of implementing this test in Vietnam in very close and easy-to-understand real stories.
Sharing about the significance of the PGT-M test with couples who are expecting children and want to perform IVF, Assoc.Prof.Tran Van Khoa, PhD.MD. said: "PGT-M is one of the most effective, most active, and earliest preventive screening measures to prevent genetic diseases. PGT-M is also a hope for couples who are unfortunate enough to carry the disease gene and are at risk of bearing a child affected."
Pham Dinh Minh, PhD. added: "Currently, most genetic diseases, especially those caused by genetic mutations, still have no treatment, if any, the price is also very high, difficult to access, causing burdens for patients' families and society. Therefore, screening and prevention of these diseases has become very important."
It can be seen that the advancement of gene sequencing technology has brought advanced solutions that greatly help the preimplantation screening process, and PGT-M is one of the most effective and outstanding solutions.
Both Assoc. Prof. Khoa and Dr. Minh agreed that: "PGT-M is a difficult test, requiring investment in advanced scientific technologies and equipment to ensure accuracy." With a laboratory system that meets ISO 13485:2016, ISO 15189:2012 standards, along with modern machines equipped with the latest technologies, GENTIS is one of the few testing centers that can perform qualified PGT-M tests, ensuring high accuracy and optimal turnaround time. From there, it helps to screen for monogenic genetic diseases effectively and provide maximum support for reproductive support purposes.
"To ensure the most accurate PGT-M test results, it is necessary to have a combination of clinicians, genetic consultants, embryologists and testing labs. GENTIS has established the Genetic Counseling Center to support clinicians and embryologists to use and understand the test in the best way" - Dr. Minh emphasized.
"Genetic counseling is often carried out in clinics, hospitals, and centers by geneticists and assisted reproductive doctors. Genetic counseling revolves around the exchange between doctors and patients, in order to provide information for doctors to identify general and genetic risks, evaluate, consider, select appropriate tests, and find out the underlying cause of the disease. The most important thing is that the genetic counseling process must ensure that three factors are accurate, complete and most suitable for the patient. The ultimate goal is that patients can participate in the treatment process and make treatment decisions that are suitable for their family circumstances," added Nguyen Thi Huyen, MSc.MD..
In addition, Dr. Huyen and experts also answered a lot of questions from the audience about monogenic genetic diseases. These are all valuable knowledge that is summarized and explained in the most understandable way for everyone.
Hopefully, the sharing of experts in the talk show will help doctors and nurses working in the field of assisted reproduction gain a lot of useful updated knowledge. At the same time, it brings a new hope to couples who unfortunately carry the disease gene and are looking forward to having children.
[content_more] => [meta_title] => TALK SHOW: "GENETIC COUNSELING FOR PGT-M SCREENING FOR EMBRYONIC MONOGENIC DISEASES: [meta_description] => GENTIS Genetic Counseling Center broadcasted the 2nd Genetic Counseling - Expert Consultation Talkshow with the topic: "Genetic counseling for PGT-M testing for screening for embryonic monogenic diseases: International recommendations and practices in Vie [meta_keyword] => genetic conseling,pgt-m,test,gentis [thumbnail_alt] => [post_id] => 1201 [category_id] => 4 ) )
Meeting Invitation annual General Meeting of shareholders 2024
GENTIS & Hanoi Hospital of Andrology and Infertility: Lighting Up the Dreams of Infertile Families
GENTIS participated in the launch ceremony of the "DFT 1:1 Model - Optimizing IVF Success Rates" at Phuong Dong General Hospital
GENTIS Service Introduction Workshop at Hong Ngoc Phuc Truong Minh IVF Center
GENTIS Launches Expanded Thalassemia Test Package
GENTIS Accompanies the 24th Vietnam - France - Asia - Pacific Obstetrics and Gynecology Conference
GENTIS - Main Sponsor of the 24th Vietnam - France - Asia - Pacific Obstetrics and Gynecology Conference
TALK SHOW: "GENETIC COUNSELING FOR PGT-M SCREENING FOR EMBRYONIC MONOGENIC DISEASES: INTERNATIONAL RECOMMENDATIONS AND PRACTICES IN VIETNAM"
Quý khách vui lòng điền thông tin bên dưới để được hỗ trợ,
tư vấn một cách tốt nhất!
Quý khách vui lòng điền thông tin bên dưới để được hỗ trợ,
tư vấn một cách tốt nhất!
